PGR and breast cancer: The expression of specific genes such as the oestrogen receptors (ERs) and HER2/neu are indicative of outcome in breast cancer patients, and the clinically relevant subgroupings are based broadly on ER/progesterone receptor (PR)/HER2/neu status.